NDC 81968-030 – Auvelity

Dextromethorphan Hydrobromide 30 mg/1; Bupropion Hydrochloride 105 mg/1 · Tablet, Multilayer, Extended Release · Oral

Human Prescription Drug

Product NDC81968-030

Product details

Brand name
Auvelity
Generic name
Dextromethorphan hydrobromide, bupropion hydrochloride
Labeler
Axsome Therapeutics, Inc.
Dosage form
Tablet, Multilayer, Extended Release
Route
Oral
Marketing category
NDA · NDA215430
Marketed since
May 8, 2026
Listing expires
December 31, 2027
Pharmacologic class
Aminoketone; Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Auvelity →

Package NDC codes (1)

Package NDCDescriptionSince
81968-030-22 sample1 BOTTLE in 1 CARTON (81968-030-22) / 21 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLEMay 8, 2026

Other Auvelity products